论文部分内容阅读
目的了解天津市2型糖尿病患者并发症对其住院费用的影响,为控制糖尿病的治疗费用提供依据。方法将天津医科大学代谢病医院2004-2010年按10%抽样的2 519例2型糖尿病住院患者按国际疾病分类分组,共8组,0组为无并发症的2型糖尿病患者,1~7组分别为合并1~7种并发症的2型糖尿病患者,分析不同组别患者的住院费用差异及其构成情况。结果 2型糖尿病患者年龄、病史、次均住院天数、年均住院次数均与并发症数量有关,8组2型糖尿病住院患者次均住院天数、年均住院次数随并发症数量增多而增加,差异有统计学意义(H值分别为71.076、39.551,P<0.01)。不同并发症数量患者药费、化验费、检查费等住院费用的差异有统计学意义(P<0.01),合并7种并发症的2型糖尿病住院患者次住院费用、药费分别是单纯2型糖尿病住院患者的1.58倍、3.09倍。结论天津市2型糖尿病患者住院费用给患者家庭和社会带来沉重的经济负担,应不断加强2型糖尿病及其并发症的防治研究,加强糖尿病卫生经济学研究。
Objective To understand the impact of complications of type 2 diabetes patients on the cost of hospitalization in Tianjin, and to provide basis for controlling the cost of diabetes treatment. Methods A total of 2 519 patients with type 2 diabetes who were sampled at 10% of the samples from the Department of Metabolism Hospital of Tianjin Medical University from 2004 to 2010 were divided into 8 groups according to the international classification of diseases. Group 0 was type 2 with no complications, Patients with type 2 diabetes mellitus who had 1 to 7 complications, respectively, were analyzed for differences in hospitalization costs and their composition in different groups. Results The age, medical history, the number of hospital stay and the average number of hospitalizations in patients with type 2 diabetes were all related to the number of complications. The average length of hospitalization and the number of hospitalizations per day in type 2 diabetic patients increased with the increase of the number of complications. There was statistical significance (H values were 71.076,39.551, P <0.01). There were significant differences in the cost of hospitalization for different complication rates such as drug fees, laboratory fees and examination fees (P <0.01). Inpatients with type 2 diabetes mellitus with 7 complications were hospitalized in cost-per-capita 1.58-fold, 3.09-fold more patients with diabetes inpatients. Conclusion The cost of hospitalization for type 2 diabetes patients in Tianjin poses a heavy financial burden on patients’ families and society. Therefore, it is necessary to strengthen prevention and treatment of type 2 diabetes mellitus and its complications and strengthen the research on the economics of diabetes mellitus.